TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 309 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,075 | -18.4% | 624 | -12.4% | 0.00% | – |
Q1 2024 | $9,890 | -2.7% | 712 | 0.0% | 0.00% | – |
Q4 2023 | $10,160 | -17.4% | 712 | -10.4% | 0.00% | – |
Q3 2023 | $12,299 | -71.8% | 795 | -71.4% | 0.00% | – |
Q2 2023 | $43,690 | +31.1% | 2,781 | +37.5% | 0.00% | – |
Q1 2023 | $33,323 | +122.5% | 2,022 | +110.6% | 0.00% | – |
Q4 2022 | $14,976 | -99.9% | 960 | 0.0% | 0.00% | – |
Q3 2022 | $12,451,000 | -76.4% | 960 | -74.5% | 0.00% | – |
Q2 2022 | $52,847,000 | -96.1% | 3,764 | -96.0% | 0.00% | -100.0% |
Q1 2022 | $1,351,479,000 | -63.7% | 94,377 | -65.4% | 0.00% | -60.0% |
Q4 2021 | $3,721,017,000 | +428.0% | 273,002 | +534.5% | 0.01% | +400.0% |
Q3 2021 | $704,733,000 | -0.6% | 43,024 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $709,149,000 | -87.0% | 42,136 | -83.7% | 0.00% | -87.5% |
Q1 2021 | $5,450,427,000 | -10.0% | 258,296 | -22.4% | 0.01% | -27.3% |
Q4 2020 | $6,058,598,000 | +9.1% | 332,890 | +7.0% | 0.01% | +37.5% |
Q3 2020 | $5,552,022,000 | -9.3% | 311,212 | -8.8% | 0.01% | -27.3% |
Q2 2020 | $6,121,212,000 | +21.1% | 341,395 | +2.6% | 0.01% | +10.0% |
Q1 2020 | $5,052,754,000 | -19.7% | 332,856 | +4.3% | 0.01% | -9.1% |
Q4 2019 | $6,294,245,000 | +16.6% | 319,019 | +1.6% | 0.01% | +10.0% |
Q3 2019 | $5,400,026,000 | -4.9% | 313,955 | -2.1% | 0.01% | -9.1% |
Q2 2019 | $5,676,124,000 | – | 320,685 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |